Sapna S Shah1, Claudia E Ramirez2, Alvin C Powers3, Chang Yu4, Cyndya A Shibao5, James M Luther6. 1. Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 3. Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN, USA; Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN, USA. 4. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA. 5. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA. 6. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: James.Luther@Vanderbilt.edu.
Abstract
OBJECTIVE: Metabolic syndrome is associated with insulin resistance and increased future risk of type 2 diabetes. This study investigates the relationship between insulin secretion, insulin resistance and individual metabolic syndrome components in subjects without a prior diagnosis of diabetes. RESEARCH DESIGN AND METHODS: We assessed insulin secretion during hyperglycemic clamps by infusing dextrose to maintain hyperglycemia (200mg/dL), followed by L-arginine administration. Studies in 98 individuals (mean age 45.3±1.2years, 56% female, 22% African-American, 49% with metabolic syndrome) were analyzed. We tested the association between the number of metabolic syndrome components and individual outcome variables using linear mixed-effects models to adjust for potential confounding effects of age, sex, and race. RESULTS: Insulin sensitivity index was reduced in the presence of 1 or more metabolic syndrome components. Insulin sensitivity was independently associated with age, waist circumference, male gender and decreased HDL cholesterol. The acute insulin response was greater with two or more metabolic syndrome components, and late glucose-stimulated and L-arginine-stimulated insulin responses exhibited a similar trend. In contrast, the disposition index, a measure of beta cell compensation for insulin resistance, was linearly lower with the number of metabolic syndrome components, and was negatively associated with age, Caucasian race, waist circumference, fasting glucose, and decreased HDL cholesterol. CONCLUSIONS: The insulin secretory response in metabolic syndrome is inadequate for the worsening insulin sensitivity, as demonstrated by a decline in disposition index. A dysfunctional insulin secretory response is evident in non-diabetic individuals and worsens with accumulation of metabolic syndrome components.
OBJECTIVE:Metabolic syndrome is associated with insulin resistance and increased future risk of type 2 diabetes. This study investigates the relationship between insulin secretion, insulin resistance and individual metabolic syndrome components in subjects without a prior diagnosis of diabetes. RESEARCH DESIGN AND METHODS: We assessed insulin secretion during hyperglycemic clamps by infusing dextrose to maintain hyperglycemia (200mg/dL), followed by L-arginine administration. Studies in 98 individuals (mean age 45.3±1.2years, 56% female, 22% African-American, 49% with metabolic syndrome) were analyzed. We tested the association between the number of metabolic syndrome components and individual outcome variables using linear mixed-effects models to adjust for potential confounding effects of age, sex, and race. RESULTS:Insulin sensitivity index was reduced in the presence of 1 or more metabolic syndrome components. Insulin sensitivity was independently associated with age, waist circumference, male gender and decreased HDL cholesterol. The acute insulin response was greater with two or more metabolic syndrome components, and late glucose-stimulated and L-arginine-stimulated insulin responses exhibited a similar trend. In contrast, the disposition index, a measure of beta cell compensation for insulin resistance, was linearly lower with the number of metabolic syndrome components, and was negatively associated with age, Caucasian race, waist circumference, fasting glucose, and decreased HDL cholesterol. CONCLUSIONS: The insulin secretory response in metabolic syndrome is inadequate for the worsening insulin sensitivity, as demonstrated by a decline in disposition index. A dysfunctional insulin secretory response is evident in non-diabetic individuals and worsens with accumulation of metabolic syndrome components.
Authors: J Eriksson; A Franssila-Kallunki; A Ekstrand; C Saloranta; E Widén; C Schalin; L Groop Journal: N Engl J Med Date: 1989-08-10 Impact factor: 91.245
Authors: Anthony J G Hanley; Lynne E Wagenknecht; Ralph B D'Agostino; Bernard Zinman; Steven M Haffner Journal: Diabetes Date: 2003-11 Impact factor: 9.461
Authors: Julia H Goedecke; Joel A Dave; Mirjam V Faulenbach; Kristina M Utzschneider; Estelle V Lambert; Sacha West; Malcolm Collins; Tommy Olsson; Brian R Walker; Jonathan R Seckl; Steven E Kahn; Naomi S Levitt Journal: Diabetes Care Date: 2009-02-05 Impact factor: 17.152
Authors: Jacob T Mey; Adithya Hari; Christopher L Axelrod; Ciarán E Fealy; Melissa L Erickson; John P Kirwan; Raed A Dweik; Gustavo A Heresi Journal: Eur Respir J Date: 2020-04-09 Impact factor: 16.671
Authors: Anna R Hemnes; J Matthew Luther; Christopher J Rhodes; Jason P Burgess; James Carlson; Run Fan; Joshua P Fessel; Niki Fortune; Robert E Gerszten; Stephen J Halliday; Rezzan Hekmat; Luke Howard; John H Newman; Kevin D Niswender; Meredith E Pugh; Ivan M Robbins; Quanhu Sheng; Cyndya A Shibao; Yu Shyr; Susan Sumner; Megha Talati; John Wharton; Martin R Wilkins; Fei Ye; Chang Yu; James West; Evan L Brittain Journal: JCI Insight Date: 2019-01-10
Authors: Gail K Adler; Gillian R Murray; Adina F Turcu; Hui Nian; Chang Yu; Carmen C Solorzano; Robert Manning; Dungeng Peng; James M Luther Journal: Hypertension Date: 2020-03-16 Impact factor: 10.190
Authors: Richard W Stahlhut; John Peterson Myers; Julia A Taylor; Angel Nadal; Jonathan A Dyer; Frederick S Vom Saal Journal: J Endocr Soc Date: 2018-09-12